| 10858366 |
Tricyclic compounds useful to treat orthomyxovirus infections |
Rama Jain, Dennis Christofer Koester, James R. MANNING, James Sutton, Benjamin R. TAFT +1 more |
2020-12-08 |
| 10780073 |
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
Joseph P. Lyssikatos, Julie Marie Hicks, Fredrik P. Marmsater |
2020-09-22 |
| 10669269 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2020-06-02 |
| 10647730 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2020-05-12 |
| 10538555 |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions |
Michael M. Miller, Claudio Mapelli, Martin Patrick Allen, Michael S. Bowsher, Eric P. Gillis +12 more |
2020-01-21 |